Rizatriptan Benzoate Tablet
Product Images NDC 82619-112

8 FDA label images from Creekwood Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 82619-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Creekwood Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (9731b7a4 3826 466c 9dac 4327be313ba8 01)

Image (9731b7a4 3826 466c 9dac 4327be313ba8 01)
Chemical structure of rizatriptan benzoate, showing the molecular arrangement including a triazole ring, an indole system, a dimethylamino group, and a benzoate moiety.*
FDA Label Image

Image (9731b7a4 3826 466c 9dac 4327be313ba8 02)

Image (9731b7a4 3826 466c 9dac 4327be313ba8 02)
A line graph displaying the estimated probability of response over time (hours post-dose) for a placebo and two doses of RIZATRIPTAN BENZOATE tablets (5 mg and 10 mg). The vertical axes represent probability percentages from 0% to 100%, and the horizontal axis shows time from 0 to 2 hours post-dose. The 10 mg dose shows the highest response probability, followed by 5 mg and placebo.*
FDA Label Image

Image (9731b7a4 3826 466c 9dac 4327be313ba8 03)

Image (9731b7a4 3826 466c 9dac 4327be313ba8 03)
A line chart showing the estimated probability of remediation or rescue over 24 hours post-dose. The graph compares placebo, 5 mg, and 10 mg doses of rizatriptan benzoate, with placebo showing the highest probability across time, followed by the 5 mg and 10 mg doses which increase more gradually.*
FDA Label Image

Image (9731b7a4 3826 466c 9dac 4327be313ba8 04)

Image (9731b7a4 3826 466c 9dac 4327be313ba8 04)
A line graph showing percent response (with 95% confidence intervals) over time in hours post stage 2 dose for Rizatriptan Benzoate compared to placebo. The x-axis represents hours post dose (0.5 to 2.0 hours), and the y-axis shows percent response from 0% to 100%. Rizatriptan Benzoate data is shown with a solid line and placebo with a dashed line.*
FDA Label Image

Image (9731b7a4 3826 466c 9dac 4327be313ba8 05)

Image (9731b7a4 3826 466c 9dac 4327be313ba8 05)
Rizatriptan Benzoate Tablets, USP 5 mg oral tablets label showing 1000 tablet count. Manufactured by V-Ensure Pharma Technologies Pvt. Ltd. in India and distributed by Creekwood Pharmaceuticals LLC, Parispany, NJ. Includes storage instructions, dispensing information, and a barcode. Marked for prescription use only.*
FDA Label Image

Image (9731b7a4 3826 466c 9dac 4327be313ba8 06)

Image (9731b7a4 3826 466c 9dac 4327be313ba8 06)
Rizatriptan Benzoate Tablets USP 5 mg unit-of-use blister pack carton from Creekwood Pharmaceuticals LLC. The carton contains 12 tablets (2 blisters of 6 tablets each). It includes storage instructions, dosage form as oral tablets, and manufacturer information for V-Ensure Pharma Technologies Pvt. Ltd., India.*
FDA Label Image

Image (9731b7a4 3826 466c 9dac 4327be313ba8 07)

Image (9731b7a4 3826 466c 9dac 4327be313ba8 07)
Label for Rizatriptan Benzoate Tablets USP 10 mg, oral tablets in a package of 1000 tablets, from Creekwood Pharmaceuticals LLC. The label includes dosage strength, storage instructions, manufacturing details, and a barcode. It indicates prescription use only and notes dispensing guidelines.*
FDA Label Image

Image (9731b7a4 3826 466c 9dac 4327be313ba8 08)

Image (9731b7a4 3826 466c 9dac 4327be313ba8 08)
Rizatriptan Benzoate Tablets, USP 10 mg oral tablet packaging label from Creekwood Pharmaceuticals LLC. The package contains 12 tablets in a 2 x 6 unit-of-use format. The label includes usage warnings, storage instructions, and manufacturing details from Venusure Pharma Technologies Pvt. Ltd., India. It is labeled Rx only with a barcode and NDC 82619-112-04.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.